skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: The following was in the Globe today and I quote: "Canaccord Genuity’s Doug Taylor lowered his Well Health Technologies Corp. to $10 from $12 with a “buy” rating, while PI Financial’s Kris Thompson cut his target to $9 from $10.50 with a “buy” rating. The AVERAGE is $10.12."

And yet is sits at $5.10. After a good, solid quarter. I just shake my head and wonder what I am missing?

If it wasn't for 5i I would have all my money in a sock hidden under the mattress.
Read Answer Asked by Bryan on April 05, 2022
Q: Hello Team,

I am interested in your opinions on both of these companies at current levels. Would you add to these names here? Also, at what price would you find them overwhelming attractive?

Thank you.
Read Answer Asked by James on April 05, 2022
Q: Topicus has a press release revealing they are going to buy a tech firm that creates vertical market software for numerous markets in Poland. I’ve converted the $ to USD because I don’t understand the currency:

Offer price: $61 million
Annual revenue: $38 million
P/S multiple: 1.6X
Free cash flow per annum: $5.5 million

1) What do you think of the deal?
2) Did Constellation Software ever buy a public company? If so, when and what was the name or names?

Thanks for the great service.
Read Answer Asked by Michael on April 04, 2022
Q: My original 5% position @ $8.18 p/p is now reduced to 3%.Your initial recommendation is $2.83 with current rating of B+.The famous billionarie,Mr Kai Sing Li is part owner. Despite so many acquistions the stock has steadily declined from a 1yr H of $8.86 in July,2021 to recent low of $3.76 in mid Jan & appears to have found a base of some $4.Good Q on Mar 31 resulted in rise of.29(after high of + .56)& dropped 0.20 to $5.01 the next trading day.Very disappointed with the performance..Your thoughts. Txs for u usual great services & views
Read Answer Asked by Peter on April 04, 2022
Q: We'd all love to get a look at a few stock prices from 5 years in the future. Get a big winner, or avoid a big loser, with no risk. If you could get a list of the prices of 10 Canadian stocks 5 years from now, which ones would you pick? Let's say stocks with a min market cap of roughly $1 billion Cdn.
Read Answer Asked by Dan on April 01, 2022
Q: Hi 5i,
I read your market update with interest. You guys tend to be adders and trimmers as I am. You made a lot of incremental adds to various positions. I was surprised by the complete exit from OTEX at 4%. I believe you said on a number of times that one should not sell a good company unless there has been a fundamental change in the company, management or outlook. I do not see any fundamental change with OTEX. You said the stock has been a laggard. One always has some laggards in a portfolio. A steady eddy name can actually help you in these markets. Removing a 4% position seems out of sync with your style.
Thanks again.

P.S. Peter, great session with TD yesterday, even though I am not really a small cap guy.
Read Answer Asked by Dave on April 01, 2022
Q: In focusing on a sector specific purchase i guess i had my blinders on about share structure of this company! I've never been a fan of the multiple share structure model. What are your thoughts about the bought deal financing and ownership situation? Would you continue to hold?
Read Answer Asked by Todd on April 01, 2022
Q: I don't know anything about technical analysis. However, looking at the chart of XBC over the past week there appear to be clear levels of support and resistance at 1.80, 1.95 and then at 2.25, Presumably this relates to investors either taking profits or exiting at a reduced loss following the recent uptick. My question: does this chart tell us anything about future levels of support or what we might expect moving forward? Thank-you for your insight.
Read Answer Asked by Stephen on April 01, 2022
Q: AKT.A has been showing better momentum lately, but I'm still way way down on this stock. Would you continue to hold or sell and use the funds to average down on Xebec?
My other 2 options are to either sell Knight Therapeutics, or use up some of my cash to top up Xebec.
I sold both TBRD and UNS near their lows only to watch them Rocket later, so this makes me hesitant on selling my losers, i often get it wrong.
Thanks
Read Answer Asked by Gordon on April 01, 2022
Q: GSY: I've been thinking about buying this stock; however, concerned about the BOC aggressive stated policy to increase interest rates quite quickly. This and the recent report from RBC on housing service index that is high and getting higher - higher % income required to service mortgage debt. Concerned about a recession; especially, if I own this stock which probably would get killed, I would think? Comments please.
Read Answer Asked by James on April 01, 2022
Q: The Montley Fool is highly recommending Acuity Ads
as a strong buy with great potential and consider it a must have in your portfolio. What are your thoughts on this stock rebounding. Would you recommend buying at this price and do you share the same optimism??? Thanks for taking my question.

Read Answer Asked by Homer on March 30, 2022
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!